After Hours: Teladoc Health (4LL.F XETRA) €4.15 +5.83% on 23 Feb 2026: watch upcoming earnings
4LL.F stock jumped after hours to €4.15, up 5.83%, on 23 Feb 2026 as traders reacted ahead of Teladoc Health’s earnings event. Volume printed at 8,254.00 versus an average of 1,369.00, signaling heavier activity in XETRA trade. The move follows sustained weakness year-to-date and a low near €3.71 this year, prompting short-term traders to reprice risk ahead of the company’s results and management commentary.
What moved 4LL.F stock in after hours
Teladoc Health, Inc. (4LL.F) climbed to €4.15 in after-hours trading on XETRA, a €0.23 gain from the previous close. The spike reflects positioning ahead of the earnings announcement on 25 Feb 2026, plus mention of rising short-interest in US listings that can influence ADR-linked flows. Trading volume reached 8,254.00, well above the average of 1,369.00, suggesting event-driven order flow rather than broad sector rotation.
4LL.F stock: fundamentals and valuation
Teladoc’s trailing metrics show EPS -1.06 and PE -3.96, reflecting ongoing losses. Valuation ratios include P/S 0.35 and P/B 0.62, which point to a discounted equity value versus book. The company reports a current ratio of 2.70 and debt-to-equity of 0.74, while free cash flow yield is approximately 15.97%, indicating operating cash generation despite net losses.
Technical view on 4LL.F stock and trading signals
Technicals show the stock below the 50-day €5.51 and 200-day €6.39 averages, with RSI at 37.93 signaling near-oversold conditions. MACD histogram is mildly positive, and Bollinger Bands place a lower band near €3.49, giving a short-term support reference. Traders should watch intraday momentum and whether price reclaims the €4.29 mid-band as a sign of stabilisation.
Meyka AI rates 4LL.F with a score out of 100 and forecast
Meyka AI rates 4LL.F with a score out of 100: 69.86/100 (Grade B, HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst sentiment. Meyka AI’s forecast model projects a 12-month target of €6.20, implying an upside of 49.40% from the current €4.15. Forecasts are model-based projections and not guarantees. The platform flags cash per share €4.13 and book value €7.92 as balance-sheet cushions.
Risks, catalysts and what to watch for 4LL.F stock
Near-term catalysts include the earnings release on 25 Feb 2026 and commentary on revenue mix between Integrated Care and BetterHelp. Key risks are continued negative EPS and interest coverage pressure. Monitor short-interest metrics and US-listed Teladoc flows; see MarketBeat coverage of short activity for related tickers MarketBeat short interest. Also track comparative coverage in sector peers and market commentary American Banking News.
Sector context and strategic takeaways for 4LL.F stock
Teladoc sits in Healthcare — Medical Information Services — a sector that shows modest YTD performance. Investors should weigh broader healthcare demand trends, mental-health platform adoption, and contract renewals. Position sizing matters: volatility remains elevated and the stock trades under its longer-term moving averages, so a measured approach tied to post-earnings guidance is prudent.
Final Thoughts
Key takeaways on 4LL.F stock: the after-hours uptick to €4.15 on 23 Feb 2026 is event-driven, tied to an imminent earnings release and heavier-than-normal volume of 8,254.00. Fundamentals show losses (EPS -1.06) but reasonable valuation ratios (P/S 0.35, P/B 0.62) and positive free cash flow yield 15.97%. Meyka AI’s model projects a €6.20 12-month target, implying 49.40% upside versus today’s price; this is a model-based projection and not a guarantee. Traders should watch the earnings print, management commentary on membership trends and margin progress, and US-listed Teladoc flows that can affect XETRA liquidity. For more data and live updates see our Meyka stock page for 4LL.F. Current technicals favour caution until the share reclaims the €5.51 50-day average, but the discounted valuation leaves room for upside if growth and guidance improve.
FAQs
What drove the after-hours move in 4LL.F stock on 23 Feb 2026?
The move followed positioning ahead of Teladoc’s earnings on 25 Feb 2026, higher-than-average volume 8,254.00, and market attention on short-interest in related US listings. Traders were pricing event risk and guidance updates.
How does Meyka AI rate 4LL.F stock and what does it mean?
Meyka AI scores 4LL.F 69.86/100 (Grade B, HOLD). The grade blends benchmark, sector, growth, metrics and analyst signals. It’s informational only and not investment advice.
What is Meyka AI’s price forecast for 4LL.F stock?
Meyka AI’s forecast model projects a 12-month target of €6.20, implying about 49.40% upside from €4.15. Forecasts are model-based projections and not guarantees.
What key risks should investors watch for 4LL.F stock?
Main risks include continued negative EPS, weak interest coverage, and revenue or membership shortfalls. Earnings guidance and US-listed flows that affect liquidity on XETRA are critical near-term risks.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.